Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001415889-25-000876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-06 | 2025-01-02 | CAPR | Bergmann Anthony | CFO | A - Grant | $0.00 | +3,342 | 5,723 | +140% | $0 |
| DM | 2025-01-06 | 2025-01-02 | CAPR | Bergmann Anthony | CFO | A - Grant | $0.00 | +81.2K | 6,170 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | A | A | 3,342 | $0.00 | 5,723 | D | — | — | (F1) Represents fully vested Restricted Stock Units as of January 2, 2025 issued for services with the Company. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-02 | A | A | 75,000 | $0.00 | 75,000 | D | $14.96 · — to 2035-01-02 | 75,000 Common Stock | (F2) The shares vest 1/48th of the first day of each month, commencing February 1, 2025, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-01-02 | A | A | 6,170 | $0.00 | 6,170 | D | $14.96 · — to 2035-01-02 | 6,170 Common Stock | (F3) The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. |